APA (7th ed.) Citation

Carroll, C., Tappenden, P., Rafia, R., Hamilton, J., Chambers, D., Clowes, M., . . . Wierzbicki, A. S. (2017). Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia: An evidence review group perspective of a NICE single technology appraisal. Springer International Publishing.

Chicago Style (17th ed.) Citation

Carroll, Christopher, Paul Tappenden, Rachid Rafia, Jean Hamilton, Duncan Chambers, Mark Clowes, Paul Durrington, Nadeem Qureshi, and Anthony S. Wierzbicki. Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Springer International Publishing, 2017.

MLA (9th ed.) Citation

Carroll, Christopher, et al. Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Springer International Publishing, 2017.